Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID

An oral pharmaceutical dosage form comprising a proton pump inhibitor and one or more prokinetic agents in a fixed formulation, wherein the proton pump inhibitor is protected by an enteric coating layer. The fixed formulation is in the f...

H Depui - US

Multiparticulate oral dosage forms

(57) Abstract: reversibly adsorbed on the ion exchange resin, and then advantageous oral dosage form comprising a coated drug in a polymer material is provided. The compositions of the present invention is especially benefit the dispensi...

カミング,ケニスイアイン，クランシー,モリスジョセフアンソニー，コッド,ジャネットエリザベス，... - WO

Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate

An oral pharmaceutical dosage form comprising an acid susceptible proton pump inhibitor and one or more antacid agents or an alginate in a fixed formulation, wherein the proton pump inhibitor is protected by an enteric coating layer and ...

DEPUI HELENE，HALLGREN AGNETA - WO

MULTIPARTICULATE COMPOSITIONS OF MILNACIPRAN FOR ORAL ADMINISTRATION

FERRARI S, FANTOLI U.

AB Fleming，J Hirsh，RV Rariy - 《Clinical Medicine》

Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID

An oral pharmaceutical dosage form comprising an acid susceptible proton pump inhibitor and one or more NSAIDs in a fixed formulation, wherein the proton pump inhibitor is protected by an enteric coating layer. The fixed formulation is i...

H Depui，P Lundberg - US

MULTIPARTICULATE ORAL DOSAGE FORMS

A convenient oral dosage form that contains a drug that is reversibly adsorbed to an ion-exchange resin and subsequently coated with a polymeric material is provided. Compositions of the invention are particularly advantageous for formul...

CUMMING Kenneth Iain，CLANCY Maurice Joseph Anthony，CODD Janet Elizabeth，...

Multiple unit effervescent dosage forms comprising proton pump inhibitor

A new tableted multiple unit effervescent dosage form containing an acid susceptible proton pump inhibitor in the form of the racemate, an alkaline salt thereof or one of its single enantiomers or an alkaline salt thereof, and effervesce...

PJ Lundberg - CA

MULTIPARTICULATE ORAL DOSAGE FORMS

not available for EP1140037of corresponding document: WO0040224 A convenient oral dosage form that contains a drug that is reversibly adsorbed to an ion-exchange resin and subsequently coated with a polymeric material is provided. Compos...

KI Cumming，MJA Clancy，JE Codd，... - EP

Polymeric compositions and dosage forms comprising the same

A dosage form comprises: (a) at least one active ingredient; (b) a core having an outer surface; and (c) a shell which resides upon at least a portion of the core outer surface, wherein at least a portion of the shell is semipermeable, s...

HY Huang，DY Lee，SP Li - WO

ORAL PHARMACEUTICAL DOSAGE FORMS COMPRISING A PROTON PUMP INHIBITOR AND AN ANTACID AGENT OR ALGINATE

An oral pharmaceutical dosage form comprising an acid susceptible proton pump inhibitor and one or more antacid agents or an alginate in a fixed formulation, wherein the proton pump inhibitor is protected by an enteric coating layer and ...

DEPUI Helene，HALLGREN Agneta - US